🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the response to the combination of Revlimid (Lenalidomide)+ Vi...
Status
Terminated
Location
Hackensack University Medical Center
Start Date
2010-07
Trial ID
NCT01241786
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of genotype...
Status
Recruiting
Location
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Start Date
2025-04-01
Trial ID
NCT06803693
Higher risk MDS with del(5q) carry very poor prognosis, but show some respo...
Status
Completed
Location
Hôpital kremlin Bicêtre
Start Date
2010-03-25
Trial ID
NCT01088373
Treatments Being Tested
At present, the main therapies for myelodysplastic syndromes with ring side...
Status
Unknown
Location
Peking union medical college hospital
Start Date
2023-08
Trial ID
NCT06004765
Treatments Being Tested
The purpose of the trial is to study how the elderly patients who have prev...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2011-08
Trial ID
NCT01442714
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of genotype...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-31
Trial ID
NCT06441097
A multi-center, open-label phase I/II study to to determine the safety and ...
Status
Completed
Location
Uniklinik Köln
Start Date
2020-05-25
Trial ID
NCT04257448
Treatments Being Tested
This study intends to use Obinutuzumab, Zanubrutinib, and Lenalidomide sequ...
Status
Unknown
Location
the First Affiliated Hospital of Soochow University
Start Date
2022-07-01
Trial ID
NCT05797948
The goal of this clinical research study is to find the highest tolerable d...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2012-04
Trial ID
NCT01200004
Treatments Being Tested
This phase II study will evaluate the safety and efficacy of combining two ...
Status
Terminated
Location
Rush University Medical Center
Start Date
2011-01
Trial ID
NCT01379274
Treatments Being Tested